A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.
- DOI
- 10.1093/infdis/jiab098
- Published
- 2021 May 20
- Container
- The Journal of infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/infdis/jiab098,
title = {A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.},
author = {Raman RS and Bhagwan Barge V and Anil Kumar D and Dandu H and Rakesh Kartha R and Bafna V and Aravinda VT and Raghuram TC},
year = {2021},
journal = {The Journal of infectious diseases},
doi = {10.1093/infdis/jiab098},
url = {https://doi.org/10.1093/infdis/jiab098}
}RIS
TY - JOUR TI - A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy. AU - Raman RS AU - Bhagwan Barge V AU - Anil Kumar D AU - Dandu H AU - Rakesh Kartha R AU - Bafna V AU - Aravinda VT AU - Raghuram TC PY - 2021 JO - The Journal of infectious diseases DO - 10.1093/infdis/jiab098 UR - https://doi.org/10.1093/infdis/jiab098 ER -
APA
RS, R., V, B. B., D, A. K., H, D., R, R. K., V, B., VT, A., & TC, R. (2021). A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiab098
Source records
- pubmed · retrieved 2026-09-25T13:33:30.429Z